| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BRIEF REVIEWS |
Divisions of
*
Pediatric Infectious Diseases and
Cardiology and the Atherosclerosis Research Center, Burns and Allen Research Institute, Cedars-Sinai Medical Center and David Geffen School of Medicine, University of California, Los Angeles, CA 90048
Chronic inflammation and disordered lipid metabolism represent hallmarks of atherosclerosis. Considerable evidence suggests that innate immune defense mechanisms might interact with proinflammatory pathways and contribute to development of arterial plaques. The preponderance of such evidence has been indirect clinical and epidemiologic studies, with some support from experimental animal models of atherosclerosis. However, recent data now directly implicate signaling by TLR4 in the pathogenesis of atherosclerosis, establishing a key link between atherosclerosis and defense against both foreign pathogens and endogenously generated inflammatory ligands. In this study, we briefly review these and closely related studies, highlighting areas that should provide fertile ground for future studies aimed at a more comprehensive understanding of the interplay between innate immune defense mechanisms, atherosclerosis, and related vascular disorders.
This article has been cited by other articles:
|
|
 |
|
  D. J. Catellier, N. Aleksic, A. R. Folsom, and E. Boerwinkle Atherosclerosis Risk in Communities (ARIC) Carotid MRI Flow Cytometry Study of Monocyte and Platelet Markers: Intraindividual Variability and Reliability Clin. Chem., August 1, 2008; 54(8): 1363 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. G. Kim, J. Y. Kim, M. G. Gim, J. M. Lee, and D. K. Chung Mechanical stress induces tumor necrosis factor-{alpha} production through Ca2+ release-dependent TLR2 signaling Am J Physiol Cell Physiol, August 1, 2008; 295(2): C432 - C439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ha, J.-H. Lee, H.-N. Kim, H. B. Kwak, H.-M. Kim, S. E. Lee, J. H. Rhee, H.-H. Kim, and Z. H. Lee Stimulation by TLR5 Modulates Osteoclast Differentiation through STAT1/IFN-{beta} J. Immunol., February 1, 2008; 180(3): 1382 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Steffens and F. Mach Adiponectin and Adaptive Immunity: Linking the Bridge From Obesity to Atherogenesis Circ. Res., February 1, 2008; 102(2): 140 - 142. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Westerterp, J. F.P. Berbee, N. M.M. Pires, G. J.D. van Mierlo, R. Kleemann, J. A. Romijn, L. M. Havekes, and P. C.N. Rensen Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E Knockout Mice Circulation, November 6, 2007; 116(19): 2173 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shinohara, K.-i. Hirata, T. Yamashita, T. Takaya, N. Sasaki, R. Shiraki, T. Ueyama, N. Emoto, N. Inoue, M. Yokoyama, et al. Local Overexpression of Toll-Like Receptors at the Vessel Wall Induces Atherosclerotic Lesion Formation: Synergism of TLR2 and TLR4 Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2384 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Sloan, P. A. Shapiro, R. E. DeMeersman, P. S. McKinley, K. J. Tracey, I. Slavov, Y. Fang, and P. D. Flood Aerobic exercise attenuates inducible TNF production in humans J Appl Physiol, September 1, 2007; 103(3): 1007 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Lepper, C. Schumann, K. Triantafilou, F. M. Rasche, T. Schuster, H. Frank, E. M. Schneider, M. Triantafilou, and M. von Eynatten Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men J. Am. Coll. Cardiol., July 3, 2007; 50(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fung, S.-M. T. Tang, J. P. Canner, K. Morishige, J. F. Arboleda-Velasquez, A. A. Cardoso, N. Carlesso, J. C. Aster, and M. Aikawa Delta-Like 4 Induces Notch Signaling in Macrophages: Implications for Inflammation Circulation, June 12, 2007; 115(23): 2948 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Mitchell, M. J Paul-Clark, G. W Clarke, S. K McMaster, and N. Cartwright Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease J. Endocrinol., June 1, 2007; 193(3): 323 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Into, Y. Kanno, J.-i. Dohkan, M. Nakashima, M. Inomata, K.-i. Shibata, C. J. Lowenstein, and K. Matsushita Pathogen Recognition by Toll-like Receptor 2 Activates Weibel-Palade Body Exocytosis in Human Aortic Endothelial Cells J. Biol. Chem., March 16, 2007; 282(11): 8134 - 8141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Seimon, A. Obstfeld, K. J. Moore, D. T. Golenbock, and I. Tabas Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages PNAS, December 26, 2006; 103(52): 19794 - 19799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Niessner, K. Sato, E. L. Chaikof, I. Colmegna, J. J. Goronzy, and C. M. Weyand Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-{alpha} Circulation, December 5, 2006; 114(23): 2482 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Lowe, T. M. Doherty, H. Karahashi, and M. Arditi Review: Ubiquitination and de-ubiquitination: role in regulation of signaling by Toll-like receptors Innate Immunity, December 1, 2006; 12(6): 337 - 345. [Abstract] [PDF]
|
|
|
|
 |
|
 H. S. Park, J. N. Chun, H. Y. Jung, C. Choi, and Y. S. Bae Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells Cardiovasc Res, December 1, 2006; 72(3): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Patrignani, C. Di Febbo, S. Tacconelli, V. Moretta, G. Baccante, M. G. Sciulli, E. Ricciotti, M. L. Capone, I. Antonucci, M. D. Guglielmi, et al. Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo Blood, May 1, 2006; 107(9): 3572 - 3574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Raines Antigen-Independent Targeting of Long-Lived CD4+ Cytolytic T Effector Cells to Lesions of Atherosclerosis Circ. Res., March 3, 2006; 98(4): 434 - 436. [Full Text] [PDF]
|
|
|
|
 |
|
 C. B Stephensen and D. S Kelley The innate immune system: friend and foe Am. J. Clinical Nutrition, February 1, 2006; 83(2): 187 - 188. [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Chen, E. Giovannucci, R. Lazarus, P. Kraft, S. Ketkar, and D. J. Hunter Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer Cancer Res., December 15, 2005; 65(24): 11771 - 11778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Rosenkranz, D. J. Schulte, L. M.A. Agle, M. H. Wong, W. Zhang, L. Ivashkiv, T. M. Doherty, M. C. Fishbein, T. J.A. Lehman, K. S. Michelsen, et al. TLR2 and MyD88 Contribute to Lactobacillus casei Extract-Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease Circulation, November 8, 2005; 112(19): 2966 - 2973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Kazemi, C. M. McDonald, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1220 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Doherty, P. K. Shah, M. Arditi, L. L. Stoll, G. M. Denning, and N. L. Weintraub Lipopolysaccharide, Toll-Like Receptors, and the Immune Contribution to Atherosclerosis Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): e38 - e39. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Harii, C. J. Lewis, V. Vasko, K. McCall, U. Benavides-Peralta, X. Sun, M. D. Ringel, M. Saji, C. Giuliani, G. Napolitano, et al. Thyrocytes Express a Functional Toll-Like Receptor 3: Overexpression Can Be Induced by Viral Infection and Reversed by Phenylmethimazole and Is Associated with Hashimoto's Autoimmune Thyroiditis Mol. Endocrinol., May 1, 2005; 19(5): 1231 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tobias and L. K. Curtiss Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis J. Lipid Res., March 1, 2005; 46(3): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Naiki, K. S. Michelsen, W. Zhang, S. Chen, T. M. Doherty, and M. Arditi Transforming Growth Factor-{beta} Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling J. Biol. Chem., February 18, 2005; 280(7): 5491 - 5495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Michelsen, T. M. Doherty, P. K. Shah, and M. Arditi Role of Toll-Like Receptors in Atherosclerosis Circ. Res., December 10, 2004; 95(12): e96 - e97. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
